Ken O'Flynn

566. Deputy Ken O'Flynn asked the Minister for Health the number of recorded cases of early pregnancy loss managed within HSE maternity hospitals ; and the number of cases managed by expectant management, medical management including pharmacological treatment such as Misoprostol, and surgical intervention; and if she will provide a breakdown by hospital group, in each of the years 2021 to 2025 and to date in 2026, in tabular form; and if she will make a statement on the matter. [36005/26]

567. Deputy Ken O'Flynn asked the Minister for Health whether any monetary approval thresholds exist within the treatment abroad scheme requiring additional sign-off for high-cost procedures; the officials or grades responsible for such approvals; and if she will provide the thresholds currently applied. [36018/26]

568. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme operates any formal value-for-money assessment process prior to approving exceptionally high-cost procedures abroad; and if so, the methodology used. [36019/26]

569. Deputy Ken O'Flynn asked the Minister for Health the number of Treatment Abroad Scheme applications approved with an estimated cost exceeding in each year since 2020 (details supplied). [36020/26]

570. Deputy Ken O'Flynn asked the Minister for Health whether any applications under the Treatment Abroad Scheme have been refused wholly or partly on financial, budgetary, or proportionality grounds since 2020; and if she will provide annual figures. [36021/26]

571. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains a central register of high-cost overseas procedures approved under the Treatment Abroad Scheme; and if so, the governance and reporting arrangements applying to that register. [36022/26]

572. Deputy Ken O'Flynn asked the Minister for Health the dates of all internal audit reviews, Comptroller and Auditor General examinations, or other formal oversight reviews conducted in respect of the Treatment Abroad Scheme since 2020; and if copies of findings or recommendations will be provided. [36023/26]

573. Deputy Ken O'Flynn asked the Minister for Health whether any risk assessment has been conducted regarding financial exposure arising from exceptionally high-cost procedures funded under the Treatment Abroad Scheme; and if so, whether she will provide details. [36024/26]

574. Deputy Ken O'Flynn asked the Minister for Health whether the Treatment Abroad Scheme has any specific governance pathway for novel, experimental, or highly specialised procedures abroad involving significant State expenditure. [36025/26]

575. Deputy Ken O'Flynn asked the Minister for Health whether the Treatment Abroad Scheme maintains procedure-specific coding or categorisation for any surgical specialties funded abroad; and if so, to provide the categories recorded. [36026/26]

576. Deputy Ken O'Flynn asked the Minister for Health whether the HSE is capable of identifying retrospectively the categories of gender affirmation procedures funded under the Treatment Abroad Scheme through MDT reports, referral documentation, consultant submissions, or reimbursement records. [36027/26]

577. Deputy Ken O'Flynn asked the Minister for Health whether any legal, GDPR, administrative, or policy barrier prevents the Treatment Abroad Scheme from recording anonymised procedure-category data for overseas gender-related surgeries. [36028/26]

578. Deputy Ken O'Flynn asked the Minister for Health whether the Internal Audit Office of the HSE or the Comptroller and Auditor General has ever examined governance, expenditure tracking, safeguarding, or procedure categorisation relating to overseas gender affirmation surgery referrals under the Treatment Abroad Scheme. [36029/26]

579. Deputy Ken O'Flynn asked the Minister for Health whether her Department has requested the introduction of structured reporting or coding mechanisms relating to gender affirmation procedures funded abroad under the Treatment Abroad Scheme. [36030/26]

580. Deputy Ken O'Flynn asked the Minister for Health the total annual expenditure under the Treatment Abroad Scheme on overseas gender-related surgical referrals for each year from 2020 to date. [36031/26]

581. Deputy Ken O'Flynn asked the Minister for Health whether the Treatment Abroad Scheme records the age profile of persons approved for overseas gender affirmation surgeries. [36032/26]

582. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any national dataset recording the number of referrals to Suicide Crisis Assessment Nurse services that are rejected, redirected, or deemed ineligible for assessment; and if not, whether she intends to introduce such reporting arrangements. [36043/26]

583. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has conducted any governance review, clinical risk assessment, or audit regarding the absence of national data collection on rejected or redirected referrals within the Suicide Crisis Assessment Nurse pathway since its implementation. [36044/26]

584. Deputy Ken O'Flynn asked the Minister for Health whether the HSE tracks outcomes for persons who are referred to Suicide Crisis Assessment Nurse services but are subsequently deemed ineligible or redirected to alternative pathways; and if not, the reason such outcome monitoring is not maintained. [36045/26]

585. Deputy Ken O'Flynn asked the Minister for Health whether the HSE tracks outcomes for persons who are referred to Suicide Crisis Assessment Nurse services but are subsequently deemed ineligible or redirected to alternative pathways; and if not, the reason such outcome monitoring is not maintained. [36046/26]

586. Deputy Ken O'Flynn asked the Minister for Health whether any adverse incident reviews, serious incident management reviews, or patient safety reviews have identified concerns regarding referrals redirected or excluded from the Suicide Crisis Assessment Nurse pathway since 2022. [36047/26]

587. Deputy Ken O'Flynn asked the Minister for Health whether the HSE can identify the number of persons who presented to emergency departments following referral, attempted referral, or redirection involving the Suicide Crisis Assessment Nurse pathway in 2025 and 2026. [36048/26]

588. Deputy Ken O'Flynn asked the Minister for Health whether the Mental Health Commission has reviewed or assessed the governance, data collection arrangements, or oversight framework associated with the Suicide Crisis Assessment Nurse service model. [36049/26]

589. Deputy Ken O'Flynn asked the Minister for Health whether the HSE intends to expand the Suicide Crisis Assessment Nurse database to include upstream referral source data, rejected referrals, redirected referrals, and cross-service pathway tracking; and if so, the timeline for implementation. [36050/26]

590. Deputy Ken O'Flynn asked the Minister for Health whether any national KPIs exist measuring repeat presentations involving persons referred through the Suicide Crisis Assessment Nurse pathway across GP, emergency department, CAMHS, and Community Mental Health Team settings. [36051/26]